Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
PVLA

PALVELLA THERAPEUTICS (PVLA) stock: insider trades, news & valuation

Net selling
Close · Oct 9, 2026 $138.77 +5.7% on the day +98.0% over 12 months 52-week range $69.90 – $158.13

Share price and insider trades

PVLA closeInsider buyInsider sale
50100150200NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $49,141 on 2026-09-02 · Christopher P KiritsyBought $49,974 on 2026-03-30 · George M JenkinsSold $266,809 on 2026-09-15 · George M JenkinsSold $341,580 on 2026-02-18 · Kathleen GoinSold $370,981 on 2025-11-19 · Kathleen GoinSold $415,014 on 2025-12-17 · Kathleen GoinSold $419,983 on 2026-01-21 · Kathleen GoinSold $475,647 on 2026-05-20 · Kathleen GoinSold $476,369 on 2026-06-17 · Kathleen GoinSold $507,607 on 2026-03-18 · Kathleen GoinSold $547,397 on 2026-04-15 · Kathleen GoinSold $642,190 on 2026-07-15 · Kathleen GoinSold $654,796 on 2026-08-19 · Kathleen GoinSold $654,917 on 2026-09-16 · Kathleen GoinBought $800,000 on 2026-02-27 · Elaine J Heron, George M JenkinsSold $1,871,463 on 2026-09-11 · George M JenkinsSold $2,028,918 on 2026-09-14 · George M Jenkins
Bought, 12 months$850K
Sold, 12 months$9.7M
Insiders buying2
Insiders selling3

PALVELLA THERAPEUTICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $850K and 3 sold $9.7M of PVLA stock on the open market.

PVLA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $786K sold (3 trades)Q4 2025Q1 2026: $850K bought (3 trades)$850KQ1 2026: $1.3M sold (7 trades)Q1 2026Q2 2026: $1.5M sold (11 trades)Q2 2026Q3 2026: $6.2M sold (22 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$6.2M22
Q2 2026—0$1.5M11
Q1 2026$850K3$1.3M7
Q4 2025—0$786K3

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.0×Last 5 sessions
Insiders' paper profit+$100KOn all tracked purchases +11.8%

Summary

Over the past 12 months, 2 PALVELLA THERAPEUTICS, INC. insiders reported open-market purchases totaling $850K, while 3 insiders reported sales totaling $9.7M. Among insiders with enough purchase history to measure, George M Jenkins (Director) has the highest Insider Score at 39. 42 of 43 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 18SEC Kathleen GoinCOO Sell Plan 1,654 $153.24 $253K -9.4% —
Sep 18SEC Kathleen GoinCOO Sell Plan 1,6592,643 held (−39%) $151.16 $251K -8.2% —
Sep 18SEC Kathleen GoinCOO Sell Plan 9891,654 held (−37%) $152.36 $151K -8.9% —
Sep 15SEC George M JenkinsDirector Sell Plan 6,520181,096 held (−3%) $150.62 $982K -7.9% 39
Sep 15SEC George M JenkinsDirector Sell Plan 6,160163,453 held (−4%) $152.12 $937K -8.8% 39
Sep 15SEC George M JenkinsDirector Sell Plan 5,632169,613 held (−3%) $151.46 $853K -8.4% 39
Sep 15SEC George M JenkinsDirector Sell Plan 4,577176,519 held (−3%) $151.72 $694K -8.5% 39
Sep 15SEC George M JenkinsDirector Sell Plan 1,560161,893 held (−1%) $153.10 $239K -9.4% 39
Sep 15SEC George M JenkinsDirector Sell Plan 1,274175,245 held (−1%) $153.06 $195K -9.3% 39
Sep 15SEC George M JenkinsDirector Sell Plan 954160,939 held (−1%) $149.38 $143K -7.1% 39
Sep 15SEC George M JenkinsDirector Sell Plan 560160,116 held (−0%) $151.33 $85K -8.3% 39
Sep 15SEC George M JenkinsDirector Sell Plan 263160,676 held (−0%) $150.40 $40K -7.7% 39
Sep 4SEC Christopher P KiritsyDirector Sell 313250 held (−56%) $157.00 $49K -11.6% —
Aug 20SEC Kathleen GoinCOO Sell Plan 1,998804 held (−71%) $151.80 $303K -8.6% —
Aug 20SEC Kathleen GoinCOO Sell Plan 1,5002,802 held (−35%) $151.39 $227K -8.3% —
Aug 20SEC Kathleen GoinCOO Sell Plan 400404 held (−50%) $153.00 $61K -9.3% —
Aug 20SEC Kathleen GoinCOO Sell Plan 302 $156.77 $47K -11.5% —
Aug 20SEC Kathleen GoinCOO Sell Plan 102302 held (−25%) $155.59 $16K -10.8% —
Jul 17SEC Kathleen GoinCOO Sell Plan 1,911 $150.25 $287K -7.6% —
Jul 17SEC Kathleen GoinCOO Sell Plan 1,0291,911 held (−35%) $149.27 $154K -7.0% —
Jul 17SEC Kathleen GoinCOO Sell Plan 8402,940 held (−22%) $148.40 $125K -6.5% —
Jul 17SEC Kathleen GoinCOO Sell Plan 5223,780 held (−12%) $147.14 $77K -5.7% —
Jun 22SEC Kathleen GoinCOO Sell Plan 2,3901,912 held (−56%) $110.26 $264K +25.9% —
Jun 22SEC Kathleen GoinCOO Sell Plan 1,88725 held (−99%) $111.31 $210K +24.7% —
Jun 22SEC Kathleen GoinCOO Sell Plan 25 $112.23 $3K +23.6% —
May 22SEC Kathleen GoinCOO Sell Plan 3,363939 held (−78%) $110.35 $371K +25.8% —
May 22SEC Kathleen GoinCOO Sell Plan 89148 held (−95%) $111.30 $99K +24.7% —
May 22SEC Kathleen GoinCOO Sell Plan 48 $111.90 $5K +24.0% —
Apr 17SEC Kathleen GoinCOO Sell Plan 1,5001,300 held (−54%) $127.13 $191K +9.2% —
Apr 17SEC Kathleen GoinCOO Sell Plan 1,5022,800 held (−35%) $125.96 $189K +10.2% —
Apr 17SEC Kathleen GoinCOO Sell Plan 639100 held (−86%) $129.17 $83K +7.4% —
Apr 17SEC Kathleen GoinCOO Sell Plan 561739 held (−43%) $128.23 $72K +8.2% —
Apr 17SEC Kathleen GoinCOO Sell Plan 100 $130.33 $13K +6.5% —
Apr 1SEC George M JenkinsDirector Buy 445187,616 held (+0%) $112.30 $50K +23.6% 39
Mar 20SEC Kathleen GoinCOO Sell Plan 2,2682,034 held (−53%) $117.56 $267K +18.0% —
Mar 20SEC Kathleen GoinCOO Sell Plan 1,730304 held (−85%) $118.37 $205K +17.2% —
Mar 20SEC Kathleen GoinCOO Sell Plan 304 $119.08 $36K +16.5% —
Mar 2SEC George M JenkinsDirector Buy 4,000187,171 held (+2%) $125.00 $500K +11.0% 39
Mar 2SEC Elaine J HeronDirector Buy 2,40047,812 held (+5%) $125.00 $300K +11.0% —
Feb 20SEC Kathleen GoinCOO Sell Plan 3,0261,276 held (−70%) $79.16 $240K +75.3% —
Feb 20SEC Kathleen GoinCOO Sell Plan 1,276 $79.97 $102K +73.5% —
Jan 23SEC Kathleen GoinCOO Sell Plan 3,749 $97.94 $367K +41.7% —
Jan 23SEC Kathleen GoinCOO Sell Plan 5533,749 held (−13%) $95.49 $53K +45.3% —
Dec 19SEC Kathleen GoinCOO Sell Plan 4,302 $96.47 $415K +43.8% —
Nov 21SEC Kathleen GoinCOO Sell Plan 2,802 $86.51 $242K +60.4% —
Nov 21SEC Kathleen GoinCOO Sell Plan 1,5002,802 held (−35%) $85.72 $129K +61.9% —

Insiders at PALVELLA THERAPEUTICS, INC.

InsiderBoughtSoldLast filingScore
George M JenkinsDirector $550K $4.2M Sep 15, 2026 39
Kathleen GoinCOO — $5.5M Sep 18, 2026 —
Elaine J HeronDirector $300K — Mar 2, 2026 —
Christopher P KiritsyDirector — $49K Sep 4, 2026 —

PVLA stock: common questions

Are PALVELLA THERAPEUTICS, INC. insiders buying PVLA stock?

In the past 12 months, 2 insiders reported open-market purchases of PVLA worth $850K. The latest was Director George M Jenkins bought $50K of PVLA at $112.30.

Are PALVELLA THERAPEUTICS, INC. insiders selling PVLA stock?

3 insiders reported sales worth $9.7M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is PVLA's 52-week range?

Over the past year PVLA has traded between $69.90 and $158.13. It last closed at $138.77 on Oct 9, 2026.